Advanced Ovarian Carcinoma Managed in an HIV-Positive Patient
This is the first report of ovarian cancer developing in a patient with HIV infection. The patient had Stage IIIC, grade 2, serous ovarian carcinoma. Aggressive therapy consisting of primary cytoreduction, high-dose platinum-based chemotherapy, and second-look laparotomy was well tolerated. The pati...
Gespeichert in:
| Veröffentlicht in: | Gynecologic oncology 1993, Vol.48 (1), p.132-134 |
|---|---|
| Hauptverfasser: | , |
| Format: | Artikel |
| Sprache: | eng |
| Schlagworte: | |
| Online-Zugang: | Volltext |
| Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
| container_end_page | 134 |
|---|---|
| container_issue | 1 |
| container_start_page | 132 |
| container_title | Gynecologic oncology |
| container_volume | 48 |
| creator | Rose, Peter G. Cheeseman, Sarah H. |
| description | This is the first report of ovarian cancer developing in a patient with HIV infection. The patient had Stage IIIC, grade 2, serous ovarian carcinoma. Aggressive therapy consisting of primary cytoreduction, high-dose platinum-based chemotherapy, and second-look laparotomy was well tolerated. The patient's CA-125 level quickly normalized but microscopic disease was found at second-look laparotomy. Although ovarian carcinoma has not been reported in the HIV-positive population, the incidence is likely to increase as the HIV-positive patient population ages and the epidemic in women continues. Aggressive primary therapy can result in a significant response; however, further experience and follow-up will be necessary to determine if there is decreased survival in this patient group as has been reported with other HIV-associated malignancies. |
| doi_str_mv | 10.1006/gyno.1993.1022 |
| format | Article |
| fullrecord | <record><control><sourceid>proquest_cross</sourceid><recordid>TN_cdi_proquest_miscellaneous_75549819</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><els_id>S009082588371022X</els_id><sourcerecordid>75549819</sourcerecordid><originalsourceid>FETCH-LOGICAL-c368t-a5d68112f9ea02d13d1c225dfbba7b40f9eec5f497062bf47a956ecdf64e832e3</originalsourceid><addsrcrecordid>eNp1kD1PwzAQhi0EKuVjZUPKgNhSbCd27YEBVUArgegArNbFviCjNgE7jcS_x1EjNiaf733udHoIuWB0xiiVNx8_TTtjWhfpy_kBmTKqRS6V0IdkSqmmueJCHZOTGD8ppQVlfEImquSpklNye-d6aCy67KWH4KHJFhCsb9otZM_QwEdKfJOl_nL1nq_b6DvfY7aGzmPTnZGjGjYRz8f3lLw93L8ulvnTy-NqcfeU20KqLgfhpGKM1xqBcscKxyznwtVVBfOqpKmPVtSlnlPJq7qcgxYSratliargWJyS6_3er9B-7zB2Zuujxc0GGmx30cyFKLViOoGzPWhDG2PA2nwFv4XwYxg1gy8z-DKDLzP4SgOX4-ZdtUX3h4-CUn415hAtbOqQZPn4h5WSJahImNpjmCz0HoOJNglKXn1A2xnX-v8u-AXrXIWN</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>75549819</pqid></control><display><type>article</type><title>Advanced Ovarian Carcinoma Managed in an HIV-Positive Patient</title><source>MEDLINE</source><source>ScienceDirect Journals (5 years ago - present)</source><creator>Rose, Peter G. ; Cheeseman, Sarah H.</creator><creatorcontrib>Rose, Peter G. ; Cheeseman, Sarah H.</creatorcontrib><description>This is the first report of ovarian cancer developing in a patient with HIV infection. The patient had Stage IIIC, grade 2, serous ovarian carcinoma. Aggressive therapy consisting of primary cytoreduction, high-dose platinum-based chemotherapy, and second-look laparotomy was well tolerated. The patient's CA-125 level quickly normalized but microscopic disease was found at second-look laparotomy. Although ovarian carcinoma has not been reported in the HIV-positive population, the incidence is likely to increase as the HIV-positive patient population ages and the epidemic in women continues. Aggressive primary therapy can result in a significant response; however, further experience and follow-up will be necessary to determine if there is decreased survival in this patient group as has been reported with other HIV-associated malignancies.</description><identifier>ISSN: 0090-8258</identifier><identifier>EISSN: 1095-6859</identifier><identifier>DOI: 10.1006/gyno.1993.1022</identifier><identifier>PMID: 8423016</identifier><identifier>CODEN: GYNOA3</identifier><language>eng</language><publisher>San Diego, CA: Elsevier Inc</publisher><subject>Adult ; AIDS/HIV ; Biological and medical sciences ; Chemotherapy, Adjuvant ; Female ; Female genital diseases ; Gynecology. Andrology. Obstetrics ; HIV Infections - complications ; Humans ; Medical sciences ; Ovarian Neoplasms - complications ; Ovarian Neoplasms - therapy ; Tumors</subject><ispartof>Gynecologic oncology, 1993, Vol.48 (1), p.132-134</ispartof><rights>1993 Academic Press</rights><rights>1993 INIST-CNRS</rights><lds50>peer_reviewed</lds50><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c368t-a5d68112f9ea02d13d1c225dfbba7b40f9eec5f497062bf47a956ecdf64e832e3</citedby></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktohtml>$$Uhttps://dx.doi.org/10.1006/gyno.1993.1022$$EHTML$$P50$$Gelsevier$$H</linktohtml><link.rule.ids>315,781,785,3551,4025,27928,27929,27930,46000</link.rule.ids><backlink>$$Uhttp://pascal-francis.inist.fr/vibad/index.php?action=getRecordDetail&idt=4611633$$DView record in Pascal Francis$$Hfree_for_read</backlink><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/8423016$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Rose, Peter G.</creatorcontrib><creatorcontrib>Cheeseman, Sarah H.</creatorcontrib><title>Advanced Ovarian Carcinoma Managed in an HIV-Positive Patient</title><title>Gynecologic oncology</title><addtitle>Gynecol Oncol</addtitle><description>This is the first report of ovarian cancer developing in a patient with HIV infection. The patient had Stage IIIC, grade 2, serous ovarian carcinoma. Aggressive therapy consisting of primary cytoreduction, high-dose platinum-based chemotherapy, and second-look laparotomy was well tolerated. The patient's CA-125 level quickly normalized but microscopic disease was found at second-look laparotomy. Although ovarian carcinoma has not been reported in the HIV-positive population, the incidence is likely to increase as the HIV-positive patient population ages and the epidemic in women continues. Aggressive primary therapy can result in a significant response; however, further experience and follow-up will be necessary to determine if there is decreased survival in this patient group as has been reported with other HIV-associated malignancies.</description><subject>Adult</subject><subject>AIDS/HIV</subject><subject>Biological and medical sciences</subject><subject>Chemotherapy, Adjuvant</subject><subject>Female</subject><subject>Female genital diseases</subject><subject>Gynecology. Andrology. Obstetrics</subject><subject>HIV Infections - complications</subject><subject>Humans</subject><subject>Medical sciences</subject><subject>Ovarian Neoplasms - complications</subject><subject>Ovarian Neoplasms - therapy</subject><subject>Tumors</subject><issn>0090-8258</issn><issn>1095-6859</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>1993</creationdate><recordtype>article</recordtype><sourceid>EIF</sourceid><recordid>eNp1kD1PwzAQhi0EKuVjZUPKgNhSbCd27YEBVUArgegArNbFviCjNgE7jcS_x1EjNiaf733udHoIuWB0xiiVNx8_TTtjWhfpy_kBmTKqRS6V0IdkSqmmueJCHZOTGD8ppQVlfEImquSpklNye-d6aCy67KWH4KHJFhCsb9otZM_QwEdKfJOl_nL1nq_b6DvfY7aGzmPTnZGjGjYRz8f3lLw93L8ulvnTy-NqcfeU20KqLgfhpGKM1xqBcscKxyznwtVVBfOqpKmPVtSlnlPJq7qcgxYSratliargWJyS6_3er9B-7zB2Zuujxc0GGmx30cyFKLViOoGzPWhDG2PA2nwFv4XwYxg1gy8z-DKDLzP4SgOX4-ZdtUX3h4-CUn415hAtbOqQZPn4h5WSJahImNpjmCz0HoOJNglKXn1A2xnX-v8u-AXrXIWN</recordid><startdate>1993</startdate><enddate>1993</enddate><creator>Rose, Peter G.</creator><creator>Cheeseman, Sarah H.</creator><general>Elsevier Inc</general><general>Elsevier</general><scope>IQODW</scope><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>7X8</scope></search><sort><creationdate>1993</creationdate><title>Advanced Ovarian Carcinoma Managed in an HIV-Positive Patient</title><author>Rose, Peter G. ; Cheeseman, Sarah H.</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c368t-a5d68112f9ea02d13d1c225dfbba7b40f9eec5f497062bf47a956ecdf64e832e3</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>1993</creationdate><topic>Adult</topic><topic>AIDS/HIV</topic><topic>Biological and medical sciences</topic><topic>Chemotherapy, Adjuvant</topic><topic>Female</topic><topic>Female genital diseases</topic><topic>Gynecology. Andrology. Obstetrics</topic><topic>HIV Infections - complications</topic><topic>Humans</topic><topic>Medical sciences</topic><topic>Ovarian Neoplasms - complications</topic><topic>Ovarian Neoplasms - therapy</topic><topic>Tumors</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Rose, Peter G.</creatorcontrib><creatorcontrib>Cheeseman, Sarah H.</creatorcontrib><collection>Pascal-Francis</collection><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>MEDLINE - Academic</collection><jtitle>Gynecologic oncology</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Rose, Peter G.</au><au>Cheeseman, Sarah H.</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Advanced Ovarian Carcinoma Managed in an HIV-Positive Patient</atitle><jtitle>Gynecologic oncology</jtitle><addtitle>Gynecol Oncol</addtitle><date>1993</date><risdate>1993</risdate><volume>48</volume><issue>1</issue><spage>132</spage><epage>134</epage><pages>132-134</pages><issn>0090-8258</issn><eissn>1095-6859</eissn><coden>GYNOA3</coden><abstract>This is the first report of ovarian cancer developing in a patient with HIV infection. The patient had Stage IIIC, grade 2, serous ovarian carcinoma. Aggressive therapy consisting of primary cytoreduction, high-dose platinum-based chemotherapy, and second-look laparotomy was well tolerated. The patient's CA-125 level quickly normalized but microscopic disease was found at second-look laparotomy. Although ovarian carcinoma has not been reported in the HIV-positive population, the incidence is likely to increase as the HIV-positive patient population ages and the epidemic in women continues. Aggressive primary therapy can result in a significant response; however, further experience and follow-up will be necessary to determine if there is decreased survival in this patient group as has been reported with other HIV-associated malignancies.</abstract><cop>San Diego, CA</cop><pub>Elsevier Inc</pub><pmid>8423016</pmid><doi>10.1006/gyno.1993.1022</doi><tpages>3</tpages></addata></record> |
| fulltext | fulltext |
| identifier | ISSN: 0090-8258 |
| ispartof | Gynecologic oncology, 1993, Vol.48 (1), p.132-134 |
| issn | 0090-8258 1095-6859 |
| language | eng |
| recordid | cdi_proquest_miscellaneous_75549819 |
| source | MEDLINE; ScienceDirect Journals (5 years ago - present) |
| subjects | Adult AIDS/HIV Biological and medical sciences Chemotherapy, Adjuvant Female Female genital diseases Gynecology. Andrology. Obstetrics HIV Infections - complications Humans Medical sciences Ovarian Neoplasms - complications Ovarian Neoplasms - therapy Tumors |
| title | Advanced Ovarian Carcinoma Managed in an HIV-Positive Patient |
| url | https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2024-12-15T09%3A35%3A39IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Advanced%20Ovarian%20Carcinoma%20Managed%20in%20an%20HIV-Positive%20Patient&rft.jtitle=Gynecologic%20oncology&rft.au=Rose,%20Peter%20G.&rft.date=1993&rft.volume=48&rft.issue=1&rft.spage=132&rft.epage=134&rft.pages=132-134&rft.issn=0090-8258&rft.eissn=1095-6859&rft.coden=GYNOA3&rft_id=info:doi/10.1006/gyno.1993.1022&rft_dat=%3Cproquest_cross%3E75549819%3C/proquest_cross%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=75549819&rft_id=info:pmid/8423016&rft_els_id=S009082588371022X&rfr_iscdi=true |